This compound displays potent PARP-1 and PARP-2 inhibition, and inhibits proliferation of breast cancer cells with mutant BRCA-1 and BRCA-2 with IC50 in the range of 10-100 nM [121]. The gene discussed is PARP1; the disease is breast carcinoma.